Overview

Update
Status
CytoPherx has been closed
Total Equity Funding
$48.2M in 3 Rounds from 11 Investors
Headquarters:
Ann Arbor, MI
Description:
CytoPherx is a medical device company offering a proprietary selective cytopheresis sytem for inflammation-based diseases and conditions.
Founders:
,
Categories:
Medical Device, Health Care, Life Science
Website:
http://www.cytopherx.com

Company Details

Update
Founded:
2007
Closed:
Closed, Date Unknown
Aliases:
Nephrion
Contact:
734-272-4772
Employees:
1 - 10 | 2 in Crunchbase

CytoPherx (formerly Nephrion) clinical stage medical device company addressing inflammation-based diseases and conditions. The company’s products are custom configurations of a proprietary selective cytopheresis-based inflammation modulating system.

Funding Rounds (4) - $50.2M

Update
DateAmount / RoundValuationLead InvestorInvestors
Jan, 2012$34M / Series C10
Jun, 2010$11.7M / Series B3
Nov, 2009$2M / Debt Financing0
Oct, 2007$2.5M / Series A3

Board Members and Advisors (3)

Update

News (5)

Update
DateNews
Mar 19, 2014SEC - SEC FORM D
Jan 3, 2014SEC - SEC FORM D
Jul 2, 2012Bloomberg - MBA Startups Find Alumni Angels With Money to Burn
Jan 4, 2012FinSMEs - FinSMEs
Jun 18, 2010Med City News - CytoPherx raises $5M to develop dialysis filters

Offices/Locations (1)

Update
  • Office

    Ann Arbor, MI

    USA

Add Acquisitions

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Images

Add Videos